Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2009 1
2010 2
2011 2
2012 5
2013 5
2014 7
2015 10
2016 7
2017 8
2018 8
2019 11
2020 12
2021 21
2022 25
2023 25

Text availability

Article attribute

Article type

Publication date

Search Results

129 results

Results by year

Filters applied: . Clear all
Page 1
Cannabidiol: pharmacology and potential therapeutic role in epilepsy and other neuropsychiatric disorders.
Devinsky O, Cilio MR, Cross H, Fernandez-Ruiz J, French J, Hill C, Katz R, Di Marzo V, Jutras-Aswad D, Notcutt WG, Martinez-Orgado J, Robson PJ, Rohrback BG, Thiele E, Whalley B, Friedman D. Devinsky O, et al. Among authors: jutras aswad d. Epilepsia. 2014 Jun;55(6):791-802. doi: 10.1111/epi.12631. Epub 2014 May 22. Epilepsia. 2014. PMID: 24854329 Free PMC article. Review.
Canadian Network for Mood and Anxiety Treatments (CANMAT) Task Force Report: A Systematic Review and Recommendations of Cannabis use in Bipolar Disorder and Major Depressive Disorder.
Tourjman SV, Buck G, Jutras-Aswad D, Khullar A, McInerney S, Saraf G, Pinto JV, Potvin S, Poulin MJ, Frey BN, Kennedy SH, Lam RW, MacQueen G, Milev R, Parikh SV, Ravindran A, McIntyre RS, Schaffer A, Taylor VH, van Ameringen M, Yatham LN, Beaulieu S. Tourjman SV, et al. Among authors: jutras aswad d. Can J Psychiatry. 2023 May;68(5):299-311. doi: 10.1177/07067437221099769. Epub 2022 Jun 16. Can J Psychiatry. 2023. PMID: 35711159 Review.
Letter in Reply.
Hassan AN, Wild C, Jutras-Aswad D. Hassan AN, et al. Among authors: jutras aswad d. J Addict Med. 2023 Jul 27. doi: 10.1097/ADM.0000000000001203. Online ahead of print. J Addict Med. 2023. PMID: 37498670 No abstract available.
Efficacy of ketamine intervention to decrease alcohol use, cravings, and withdrawal symptoms in adults with problematic alcohol use or alcohol use disorder: A systematic review and comprehensive analysis of mechanism of actions.
Garel N, McAnulty C, Greenway KT, Lesperance P, Miron JP, Rej S, Richard-Devantoy S, Jutras-Aswad D. Garel N, et al. Among authors: jutras aswad d. Drug Alcohol Depend. 2022 Oct 1;239:109606. doi: 10.1016/j.drugalcdep.2022.109606. Epub 2022 Aug 20. Drug Alcohol Depend. 2022. PMID: 36087563 Free article. Review.
The OPTIMA study, buprenorphine/naloxone and methadone models of care for the treatment of prescription opioid use disorder: Study design and rationale.
Socias ME, Ahamad K, Le Foll B, Lim R, Bruneau J, Fischer B, Wild TC, Wood E, Jutras-Aswad D. Socias ME, et al. Among authors: jutras aswad d. Contemp Clin Trials. 2018 Jun;69:21-27. doi: 10.1016/j.cct.2018.04.001. Epub 2018 Apr 5. Contemp Clin Trials. 2018. PMID: 29627621 Free PMC article. Clinical Trial.
Die 'Richtlinien für die Risiko-Reduzierung beim Cannabiskonsum (RRRCK)': EMPFEHLUNGEN[The 'Lower-Risk Cannabis Use Guidelines (LRCUG)': RECOMMENDATIONS (GERMAN)].
Fischer B, Robinson T, Bullen C, Curran V, Jutras-Aswad D, Medina-Mora ME, Pacula R, Rehm J, Room R, van den Brink W, Hall W. Fischer B, et al. Among authors: jutras aswad d. Int J Drug Policy. 2023 Mar 24:103995. doi: 10.1016/j.drugpo.2023.103995. Online ahead of print. Int J Drug Policy. 2023. PMID: 36967339 No abstract available.
Epidemiology of Injection Drug Use: New Trends and Prominent Issues.
Roy É, Arruda N, Bruneau J, Jutras-Aswad D. Roy É, et al. Among authors: jutras aswad d. Can J Psychiatry. 2016 Mar;61(3):136-44. doi: 10.1177/0706743716632503. Epub 2016 Feb 10. Can J Psychiatry. 2016. PMID: 27254088 Free PMC article. Review.
Les 'Lignes Directrices Pour l'Usage du Cannabis à Moindre Risque (LUCMR)': RECOMMENDATIONS [The 'Lower-Risk Cannabis Use Guidelines (LRCUG)': RECOMMENDATIONS (FRENCH)].
Fischer B, Robinson T, Bullen C, Curran V, Jutras-Aswad D, Medina-Mora ME, Pacula R, Rehm J, Room R, van den Brink W, Hall W. Fischer B, et al. Among authors: jutras aswad d. Int J Drug Policy. 2023 Apr 11:103994. doi: 10.1016/j.drugpo.2023.103994. Online ahead of print. Int J Drug Policy. 2023. PMID: 37055339 No abstract available.
Las 'Guías para el Uso de Cannabis de Menor Riesgo (GUCMR)': RECOMENDACIONES [The 'Lower-Risk Cannabis Use Guidelines (LRCUG)': RECOMMENDATIONS (SPANISH)].
Fischer B, Robinson T, Bullen C, Curran V, Jutras-Aswad D, Medina-Mora ME, Pacula R, Rehm J, Room R, van den Brink W, Hall W. Fischer B, et al. Among authors: jutras aswad d. Int J Drug Policy. 2023 Apr 11:103996. doi: 10.1016/j.drugpo.2023.103996. Online ahead of print. Int J Drug Policy. 2023. PMID: 37055340 No abstract available.
129 results